Xinsheng Liao
Medical Oncology · Bellevue, WANPI 1619963543
Payments from drug & device makers
Across 163 payments — averaging $22.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$391
- Daiichi Sankyo Inc.$328
- Exelixis Inc.$304
- AstraZeneca$303
- E.r. Squibb & Sons, L.L.C.$293
- Amgen$232
- plus $2K from 30 others
What the payments were for
- Food & beverage$3,54897%
- Education$913%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 16 | $391 |
| Daiichi Sankyo Inc. | 11 | $328 |
| Exelixis Inc. | 4 | $304 |
| AstraZeneca(2 entities) | 11 | $303 |
| E.r. Squibb & Sons, L.L.C. | 19 | $293 |
| Amgen | 11 | $232 |
| Novartis | 11 | $194 |
| Johnson & Johnson | 10 | $183 |
| Astellas Pharma US Inc | 6 | $161 |
| Bayer | 7 | $150 |
| Merck | 9 | $135 |
| Genentech, Inc. | 1 | $132 |
| Pfizer | 11 | $120 |
| Genentech USA, Inc. | 6 | $107 |
| Seagen Inc. | 4 | $82 |
| Sanofi | 3 | $70 |
| AbbVie | 2 | $41 |
| Bristol Myers Squibb | 2 | $41 |
| Ipsen Biopharmaceuticals, Inc | 2 | $39 |
| Taiho Oncology, Inc. | 1 | $32 |
| Janssen Scientific Affairs, LLC | 1 | $28 |
| Tesaro, Inc. | 1 | $27 |
| Agios Pharmaceuticals, Inc. | 1 | $23 |
| Array Biopharma Inc | 1 | $23 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
| Mylan Institutional Inc. | 1 | $20 |
| Coherus Oncology, Inc. | 1 | $19 |
| Incyte Corporation | 1 | $18 |
| Innate Pharma, Inc | 1 | $18 |
| Pharmacyclics LLC, An Abbvie Company | 1 | $18 |
| Sanofi-aventis U.S. LLC | 1 | $17 |
| Eisai Inc. | 1 | $16 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $14 |
| Beigene USA, Inc. | 1 | $13 |
| Clovis Oncology, Inc. | 1 | $12 |
| Puma Biotechnology, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,639 in reported general payments places this provider in the 30th percentile of 162 medical oncology providers in Washington.
Other medical oncology in Bellevue
- Michael SchweizerSeattle$27.4M
- Ajay GopalSeattle$14.6M
- Scott TykodiSeattle$14.2M
- Evan YuSeattle$9.8M
- Christina BaikSeattle$9M
- David MaloneySeattle$8.5M
- Shailender BhatiaSeattle$7.5M
- Andrew CovelerSeattle$7.1M
- William BensingerLakewood$6.9M
- Jennifer SpechtSeattle$6.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.